Evaxion A/S has filed an amendment to its registration statement with the US SEC related to a 2025 debt settlement agreement with the European Investment Bank (EIB). Under the agreement, EIB converted €3.5 million of its loan into warrants to buy Evaxion shares, which may be resold after registration approval. Evaxion is not raising capital through this filing and will not receive proceeds from any resale of shares by EIB. The deal improved Evaxion's equity and financial flexibility by reducing liabilities and simplifying its balance sheet.
Evaxion's recent SEC filing on its 2025 EIB debt settlement agreement provides context for readers. For those following health-sector stocks, 121 of 150 US health stocks on Pluang rose, while 18 fell as of Nov 09, 2026 19:41 WIB. Notable movers include ABEO at USD 3.65 with a -12.47% change, IMVT at USD 33.50 up 9.73%, and INO at USD 1.32 up 8.64%.
Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...
Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...
Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...
Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...
ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...
